Healthways Price Target Lowered to $17.00 at Stifel Nicolaus (HWAY)
Equities research analysts at Stifel Nicolaus reduced their price objective on shares of Healthways (NASDAQ:HWAY) from $19.00 to $17.00 in a research note issued to investors on Friday, American Banking & Market News reports. The firm currently has a “buy” rating on the stock. Stifel Nicolaus’ price target points to a potential upside of 48.99% from the stock’s previous close.
Healthways (NASDAQ:HWAY) opened at 11.41 on Friday. Healthways has a 52-week low of $8.58 and a 52-week high of $22.20. The stock has a 50-day moving average of $18.83 and a 200-day moving average of $15.20. The company has a market cap of $392.5 million and a price-to-earnings ratio of 972.94.
Healthways (NASDAQ:HWAY) last issued its quarterly earnings data on Thursday, October 24th. The company reported $0.05 earnings per share for the quarter, missing the analysts’ consensus estimate of $0.13 by $0.08. The company had revenue of $166.60 million for the quarter, compared to the consensus estimate of $185.74 million. During the same quarter last year, the company posted $0.15 earnings per share. Healthways’s revenue was up .0% compared to the same quarter last year. On average, analysts predict that Healthways will post $0.21 earnings per share for the current fiscal year.
Several other analysts have also recently commented on the stock. Analysts at Dougherty & Co cut their price target on shares of Healthways from $22.00 to $17.00 in a research note to investors on Friday. They now have a “buy” rating on the stock. Separately, analysts at Barclays cut their price target on shares of Healthways from $14.00 to $9.00 in a research note to investors on Friday. They now have an “underweight” rating on the stock. Finally, analysts at Credit Suisse initiated coverage on shares of Healthways in a research note to investors on Tuesday. They set a “neutral” rating on the stock. Two investment analysts have rated the stock with a sell rating, six have assigned a hold rating and four have issued a buy rating to the stock. The stock currently has a consensus rating of “Hold” and an average price target of $16.00.
Healthways, Inc provides solutions to help people improve physical, emotional and social well-being. The Company provides specific and personalized interventions for each individual in a population, irrespective of health status, age or payor.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.